Table 1

Demographic characteristics of patients with prostate cancer stratified by the previous use or non-use of ADT (n=10 893)

CharacteristicPatients not receiving ADT (n=3631)Patients receiving ADT (n=7262)P value
Total noColumn %Total noColumn %
Age (years), mean (SD)74.26 (8.81)74.46 (8.81)0.284
Urbanisation level0.792
1 (most urbanised)94325.97181625.01
287123.99173423.88
349213.55102414.10
449213.55101113.92
5 (least urbanised)83322.94167723.09
Geographic region0.454
 Northern187651.67367650.62
 Central85023.41168823.24
 Southern86023.68178924.64
 Eastern451.241091.50
Monthly income0.385
 NT$0–15 840242666.81482666.46
 NT$15 841–25 00093225.67193126.59
 ≥NT$25 0012737.525056.95
Hypertension204756.38409956.440.946
Hyperlipidaemia71819.77130818.010.026
Diabetes79221.81151120.810.226
Coronary heart disease83823.08167923.120.962
Inflammatory bowel disease290.80650.900.608
Gastrointestinal bleeding1223.362653.650.442
Previous cancers3489.585337.34<0.001
  • The average exchange rate in 2015 was US$1.00 ≈ NT$30.

  • ADT, androgen deprivation therapy; NT, New Taiwan.